Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases

Paul H Davis1, Samuel L Stanley

  • 1Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S Euclid Avenue, St Louis, MO 63110, USA.

Cellular Microbiology
|December 4, 2003
PubMed

Insights

Mouse-human chimeras offer a novel model for studying infectious diseases. These human xenografts in mice accurately replicate human infections, aiding research into pathogens and treatments.

Area of Science:

  • Microbiology and Immunology
  • Infectious Disease Modeling

Background:

  • Mouse-human chimeras are emerging as valuable tools for studying host-pathogen interactions.
  • Human xenografts in severe combined immunodeficient (SCID) mice enable modeling of various human diseases.

Purpose of the Study:

  • To review recent studies utilizing mouse-human chimeras for understanding infectious disease pathophysiology.
  • To highlight the utility of these models in studying bacterial and protozoan infections.

Main Methods:

  • Utilizing severe combined immunodeficient (SCID) mice engrafted with human cells, tissues, or organs.
  • Employing these mouse-human chimeras to model specific human infectious diseases.
  • Analyzing disease progression and host responses within the xenograft model.

Main Results:

  • Human xenografts in SCID mice accurately reproduce human disease characteristics.
  • These models facilitate the identification of microbial virulence factors.
  • They aid in understanding host responses to infection and evaluating therapeutic interventions.

Conclusions:

  • Mouse-human chimeras provide a powerful platform for preclinical research in infectious diseases.
  • These models are instrumental in advancing our understanding of disease mechanisms and developing new treatments.
  • The review summarizes key findings from studies using these advanced xenograft models.